Related Experiment Video
Updated: Mar 1, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.1K
Aging and sexual health: getting to the problem
Ecem Kaya1, Suresh C Sikka2, Philip J Kadowitz2
1a Department of Biochemistry and Pharmacology , Faculty of Pharmacy, Ankara University , Ankara , Turkey and.
Summary
Aging impairs penile function, leading to erectile dysfunction (ED) by altering smooth muscle and vascular structures. However, age is not a barrier to ED treatment, with therapies like testosterone and PDE-5 inhibitors proving effective.
Area of Science:
- Urology
- Andrology
- Gerontology
Background:
- Erectile dysfunction (ED) is a prevalent condition in aging males, frequently linked to age-related comorbidities.
- The aging process significantly impacts penile structural integrity and function, affecting smooth muscle cells and vascular architecture.
- These age-related changes impair penile hemodynamics, leading to reduced smooth muscle relaxation, elasticity, compliance, and increased fibrosis.
Purpose of the Study:
- To elucidate the mechanisms underlying erectile dysfunction (ED) in the context of penile aging, synthesizing experimental and clinical data.
- To identify research gaps and areas requiring further investigation in aging-associated ED.
- To explore novel therapeutic strategies based on a clearer understanding of aging-related molecular mechanisms in the corpus cavernosum.
Main Methods:
- Comprehensive literature review of experimental and clinical data on penile aging and ED.
- PubMed database search strategies were employed to identify relevant studies.
- Analysis of molecular mechanisms associated with corpus cavernosum aging and ED.
Main Results:
- Aging induces structural and functional modifications in penile tissues, contributing to ED.
- Impaired cavernosal smooth muscle relaxation, reduced penile elasticity, and fibrosis are key consequences of aging.
- Molecular mechanisms driving corpus cavernosum aging and ED require further clarification for therapeutic advancements.
Conclusions:
- Clarifying molecular mechanisms of aging-related ED can pave the way for innovative, mechanism-based treatments.
- Age is not a contraindication for ED management; effective treatments are available at any age.
- Combined therapies, such as testosterone replacement and phosphodiesterase-5 (PDE-5) inhibitors, show synergistic benefits for aging-related ED.
Related Concept Videos
01:20Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
01:19The Effect of Aging on Tissues
4.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
01:28Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
01:29Bone Disorders
5.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.7K
01:26Aging
908
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
908
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285